# Glycine Skin Hydration Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/glycine-skin-hydration-randomized-trial-evidence-review
Category: evidence-review
Summary: Glycine Skin Hydration Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are
Last reviewed: 2026-08-10
Reviewed by: Migaku Evidence Review
# Glycine Skin Hydration Randomized Trial: What the Evidence Says

## Quick Answer

Glycine Skin Hydration Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy and Safety of a Novel Sodium Hyaluronate Composite Solution via Mesotherapy for Facial Rejuvenation: A Multicenter Randomized Controlled Study | randomized trial | 2 | 2026-06-01 | 10.1097/GOX.0000000000007853 |
| Collagen, Curcumin, and Glutathione to Enhance Dermal Health in Aging Women with Declining Estrogen Levels &#8212;A Narrative Review | preclinical study | 4 | 2026-04-29 | 10.1007/s13555-026-01731-z |

## What The Sources Report

- Skin hydration/elasticity improved sustainably for 3 months, with only 1.67% adverse events and no serious ones. [Yang Rongya (2026); evidence level 2]
- This large-scale randomized controlled trial complements the existing evidence base for the novel sodium hyaluronate composite, strongly supporting its safty and clinical efficacy in facial rejuvenation through mesotherapy. [Yang Rongya (2026); evidence level 2]
- Collagen, along with antioxidants such as curcumin and glutathione, have gained increased utilization/awareness in recent years, providing dermal health benefits especially in women who experience declining or loss of estrogen with aging. [Arbex Priscila (2026); evidence level 4]
- The evidence of oral collagen as a nutraceutical is robust for improving several aspects of dermal health. [Arbex Priscila (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For glycine skin hydration randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Yang Rongya (2026). Efficacy and Safety of a Novel Sodium Hyaluronate Composite Solution via Mesotherapy for Facial Rejuvenation: A Multicenter Randomized Controlled Study. DOI: 10.1097/GOX.0000000000007853. PMCID: PMC13300611. PMID: 42367716. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution-Non Commercial-No Derivatives License.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13300611/
- Arbex Priscila (2026). Collagen, Curcumin, and Glutathione to Enhance Dermal Health in Aging Women with Declining Estrogen Levels &#8212;A Narrative Review. DOI: 10.1007/s13555-026-01731-z. PMCID: PMC13237322. PMID: 42056376. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This article is licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13237322/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.